NCT05031910Recruiting
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Preoperative Virtual Reality and 3D Pathologic Modeling as Treatment for Head and Neck Squamous Cell Carcinoma
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary communication between surgeons and pathologists during the treatment of head and neck squamous cell cancer and ultimately increase the accuracy of planning, the quality of communication, and maximize the outcome patients with head and neck cancer experience throughout treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 31 Aug 2021
- Start date
- Feb 2022
- Primary completion date
- Feb 2027
- Lead sponsor
- Thomas Jefferson University
- Diseases
- Head and neck cancer
- NCT number
- NCT05031910
What you commit to
- Study type: Interventional
- Planned participants: 160
- From Feb 2022 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications for surgery
Other
- Impaired judgement or those unable to provide informed consent
- Any factor that would place the patient at increased risk or preclude the individual's full compliance with or completion of the study
- Nasopharyngeal carcinoma
- Enrollment in other clinical trial
Who the study is looking for
- Diagnosed with cancer of the head and neck (oral cavity, oropharynx, larynx, hypopharynx, T1-T4)
- Receiving treatment at Thomas Jefferson University - Center City by a fellowship-trained HNC surgeon
- Eligible for definitive resection
- Age \> 18
- Provide signed written informed consent document
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sidney Kimmel Cancer Center at Thomas Jefferson University Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.